Essential Oil Compositions and Biological Activities of Broussonetia papyrifera Aerial Parts: An Integrated In Vitro and In Silico Study Authors: Ty Viet Pham, Nguyen Thi Thoa, Nguyen Thi Huong, Le The Hoai, Tran Quang Hai, Shaza W Shantier, Nguyen Thi Kim Thanh, Phan Hong Minh, Huynh Thi Ngoc Ni, Vo Thi Dung, Ninh The Son Published: 2026 ABSTRACT ABSTRACTThe current study offers an integrated in vitro and in silico evaluation of the chemical composition and biological activities of the essential oils from Broussonetia papyrifera (L.) Vent. stem bark and leaves, collected in Vietnam. The oils were predominant by oxygenated sesquiterpenes. Major compounds in the stem bark oil included (Z)‐dihydro‐apofarnesol (13.84%), ishwarane (8.96%), spathulenol (7.87%), palmitic acid (7.58%), and (E)‐dihydro‐apofarnesol (6.71%), while the leaf oil was characterized by spathulenol (34.78%), n‐hexanol (16.64%), ishwarane (7.33%), and (Z)‐dihydro‐apofarnesol (6.41%). B. papyrifera essential oils showed moderate cytotoxicity against MCF‐7 and HepG2 cancer cell lines, with IC50 values of 33.2–56.3 µg/mL. The oils strongly scavenged DPPH radicals with IC50 values of 33.15–47.83 µg/mL, as well as remarkably inhibited nitric oxide (NO) and prostaglandin E2 (PGE2) production with IC50 values of 24.15–88.70 µg/mL. In silico ADME and toxicity predictions indicated favorable drug‐likeness, good gastrointestinal absorption, and low toxicological risk for the major compounds. Molecular docking revealed stable binding of the major compounds to protein targets cyclooxygenase‐1 (COX‐1), COX‐2, 5‐lipoxygenase (5‐LOX), and xanthine oxidase (XO), with binding energies ranging from −4.3 to −8.0 kcal/mol. Collectively, B. papyrifera essential oils are promising sources of bioactive compounds with antioxidant and anti‐inflammatory potential.Keywords: anti‐inflammatory activity, Broussonetia papyrifera, molecular docking, sesquiterpene alcohols, spathulenol Introduction Broussonetia papyrifera (L.) Vent., (syn. Morus papyrifera L.), commonly known as paper mulberry, belongs to the family Moraceae and is widely distributed in East and Southeast Asia, including China, Korea, Japan, and Vietnam [1]. The plant has long been cultivated for its fibrous bark, traditionally used to produce paper, textiles, and various handicrafts [2, 3]. In addition to its economic value, B. papyrifera has been extensively used in traditional medicine systems for the treatment of inflammatory disorders, infectious diseases, edema, and metabolic‐related conditions [2, 3]. Phytochemical investigations of B. papyrifera revealed a diverse array of secondary metabolites, including flavonoids, phenolic acids, lignans, prenylated chalcones, coumarins, and alkaloids [3]. Notably, prenylated flavonoids and chalcones isolated from different parts of the plant, such as the roots, bark, and leaves, have attracted significant attention due to their remarkable biological activities [4]. These isolated compounds are considered major contributors to the pharmacological properties of the plant. Pharmacological studies have demonstrated that the extracts and isolated compounds from B. papyrifera exhibit a wide range of pharmacological activities, including anticancer, antioxidant, anti‐inflammatory, antimicrobial, antidiabetic, antigout, antinociceptive, hepatoprotective, and neuroprotective effects [3]. Several studies have reported potent inhibition of key enzymes related to inflammation and glucose metabolism, as well as strong cytotoxic activity against various human cancer cell lines [2, 3]. Moreover, recent investigations have highlighted the potential of B. papyrifera constituents in modulating molecular targets associated with oxidative stress and chronic inflammatory pathways [1]. It is noted that gas chromatography‐mass spectrometry (GC‐MS) is a rapid and reliable analytical technique widely used for the efficient identification and characterization of volatile constituents. Accordingly, several previous studies have reported GC‐MS‐based phytochemical profiling of compounds from Broussonetia species. From GC‐MS analysis, fatty acids and triterpenoids were characteristic compounds of the MeOH, n‐hexane, and EtOAc extracts of B. luzonica leaves [5]. GC‐MS analysis of B. papyrifera fruit MeOH extract exhibited the appearance of acid‐containing compounds [6]. The essential oil of B. papyrifera seeds was dominated by hexadecanoic acid (43.6%), heptadecene‐8‐carbonic acid (17.5%), and caryophyllene (8.4%) [7]. Essential oils, as complex mixtures of low‐molecular‐weight volatile secondary metabolites, are of growing interest not only for their pharmacological potential but also for their broader roles in plant defense, ecological interactions, and applications in the food, cosmetic, and agrochemical industries; recent comprehensive profiling studies of plant essential oils continue to underscore their chemodiversity and multifunctional bioactivity [8, 9]. To date, comprehensive studies integrating chemical characterization with biological evaluation of essential oils from B. papyrifera stem bark and leaves are not available. The current research aims to characterize their volatile compositions through GC‐MS analysis and to assess their therapeutic potential in cytotoxic, antioxidant, anti‐inflammatory, and antimicrobial applications. The experimental results have been further aided by ADME (absorption, distribution, metabolism, and excretion), physicochemical property, toxicology risk prediction, and molecular docking simulation. Materials and Methods Plant Materials B. papyrifera aerial parts were collected in October 2025 from Hoa Binh Park, Xuan Dinh, Hanoi, Vietnam (21°03'53'' N, 105°47'15'' E), at the vegetative stage during the autumn season. The collected samples consisted of fresh stem bark and leaves. Botanical authentication was performed by the taxonomist Nguyen Kim Dao, the Institute of Biology, VAST. Voucher specimens (BPS‐2025 for stem bark and BPL‐2025 for leaves) were deposited in the herbarium of the Institute of Chemistry, VAST. Hydrodistillation The fresh stem bark (2.0 kg) was cut into small pieces and subjected to hydrodistillation using a Clevenger‐type apparatus. The sample was immersed in 4 L of distilled water and distilled for 3 h at atmospheric pressure. After completion of the distillation process, the essential oil layer was separated from the aqueous phase, dried over anhydrous sodium sulfate, filtered, and stored in sealed amber vials at 4°C until further analysis. The same manner was applied to the fresh leaf sample (2.0 kg total), which was hydrodistilled separately from the stem bark in successive batches of approximately 200–250 g per run using the same apparatus and conditions, with the resulting oils pooled prior to storage. The oil yield was calculated on a fresh‐weight basis at 0.28% (w/w) for the stem bark and 0.29% (w/w) for the leaves. GC‐MS Analysis The chemical compositions of the essential oils were analyzed using a Shimadzu GC‐MS‐QP2010 Plus system (Shimadzu, Kyoto, Japan) equipped with a fused silica Equity‐5 capillary column (30 m × 0.25 mm i.d., 0.25 µm film thickness) [10]. Helium was used as the carrier gas at a constant flow rate of 1.0 mL/min. The injector temperature was established at 260°C, with a split ratio of 1:20. The oven temperature program was as follows: initial temperature at 50°C (held for 2 min), increased to 250°C at a rate of 4°C/min, and held at this temperature for 9 min. The MS was operated in electron impact (EI) mode at 70 eV, with a scan range of m/z 40‐500. The ion source and interface temperatures were set at 210°C and 260°C, respectively. Retention indices (RI) were obtained using a homologous series of C7‐C40 n‐alkanes under the same chromatographic conditions. The identification of the constituents was based on the comparison of their mass spectra with those in the NIST 11 and Wiley 7 libraries, further supported by the Adams mass‐spectral/retention‐index library [11] and by comparison of their calculated RI with literature data, RI being calculated according to the linear (Kováts‐type) temperature‐programmed retention‐index method of Van Den Dool and Kratz [12]. The quantification of each volatile constituent was calculated, based on the relative peak area obtained from the total ion chromatogram (TIC) of the GC‐MS run, without flame‐ionization detection (GC‐FID) or compound‐specific response‐factor correction; the reported percentages therefore represent semi‐quantitative estimates of relative abundance rather than absolute concentrations, averaged from three technical replicate injections of the same oil sample. Cytotoxic Assay The cytotoxic activity of essential oils was evaluated on MCF‐7 (human breast cancer, ATCC, HTB‐22 [RRID:CVCL_0031], Manassas, VA, USA) and HepG2 (human hepatocellular carcinoma, ATCC HB‐8065 [RRID:CVCL_0027], Manassas, VA, USA) using the 3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5 diphenyl tetrazolium bromide (MTT) colorimetric assay [13]. Briefly, cells were seeded into 96‐well plates at an appropriate density and allowed to adhere overnight under standard culture conditions (37°C and 5% CO2). The cells were then treated with various concentrations of essential oils (0.8–100 µg/mL) for 48 h, while untreated cells served as the control. After the incubation period, MTT solution was added to each well, and the plates were further incubated to allow the formation of formazan crystals by metabolically active cells. Subsequently, the culture medium was carefully removed, and the formazan crystals were dissolved in dimethyl sulfoxide (DMSO). The absorbance was measured at 570 nm using a BioTek microplate reader. Cell inhibition was expressed as a percentage relative to the untreated control (Equation 1), and the half‐maximal inhibitory concentration (IC50) values were calculated from dose‐response curves using GraphPad Prism version 7. X control and X sample stand for the absorbance of the control (without inhibitor) and absorbance in the presence of the test sample, respectively. The assay was carried out in triplicate. Ellipticine (0.1‐10 µg/mL) was used as a positive control, while 10% DMSO served as the negative control. Antioxidative Assay Antioxidant activity of the essential oils was evaluated using the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) radical scavenging assay [14]. Briefly, a freshly prepared DPPH solution in EtOH (0.15 mM) was mixed with the essential oils (5‐250 µg/mL) in 96‐well microplates. The reaction mixture was incubated at room temperature in the dark for 30 min to allow complete interaction between the DPPH radicals and the test samples. After incubation, the decrease in absorbance was measured at 517 nm using a BioTek microplate reader. EtOH was used as the blank, while ascorbic acid (0.1‐10 µg/mL) served as the positive control. The assay was carried out in triplicate. The radical scavenging activity was expressed as the percentage of inhibition relative to the control (Equation 1), and IC50 values were calculated from dose‐response curves using GraphPad Prism version 7. Anti‐Inflammatory Assay Nitric Oxide (NO) Inhibitory Assay The anti‐inflammatory potential of the essential oils was evaluated by determining their inhibitory effects on NO production in lipopolysaccharide (LPS)‐activated RAW 264.7 macrophages [15]. RAW 264.7 cells were plated in 96‐well plates at a density of 2 × 105 cells/well and incubated for 24 h at 37°C in a humidified atmosphere containing 5% CO2 using Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Following cell attachment, the medium was replaced with serum‐free DMEM to minimize potential interference from serum constituents. The cells were then exposed to various concentrations of the essential oils (4‐256 µg/mL) in the presence of LPS (1.0 µg/mL) for an additional 24 h. The accumulation of NO2 −, a stable metabolite of NO and a commonly used indicator of NO production, was measured using the Griess assay [15]. In brief, 100 µL of culture supernatant was combined with 50 µL of 1% (w/v) sulfanilamide solution in 5% (v/v) phosphoric acid and 50 µL of 0.1% (w/v) N‐(1‐naphthyl)ethylenediamine dihydrochloride (NED) in a 96‐well plate. After incubation at room temperature for 10 min, the absorbance was recorded at 540 nm using a BioTek microplate reader. NaNO2 was used to generate a standard calibration curve for the quantification of nitrite levels. The assay was carried out in triplicate. N G‐monomethyl‐L‐arginine acetate (L‐NMMA, 0.1‐10 µg/mL) was used as a positive control. The percentage of inhibition was relative to the control (Equation 1), and IC50 values were calculated from dose‐response curves using GraphPad Prism version 7. Prostaglandin E2 (PGE2) Inhibitory Assay The inhibitory effect of the essential oils on the PGE2 production was also evaluated in LPS‐stimulated RAW 264.7 macrophages [16]. RAW 264.7 cells were seeded in 96‐well plates at a density of 2 × 105 cells/well and incubated for 24 h at 37°C in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% FBS. After cell attachment, the culture medium was replaced with serum‐free DMEM, and the cells were treated with the essential oils (4–256 µg/mL) in the presence of LPS (1.0 µg/mL) for 24 h. Following treatment, the culture supernatants were collected, and the PGE2 levels were quantified using a commercially available enzyme‐linked immunosorbent assay (ELISA) kit according to the manufacturer's instructions. Briefly, aliquots of the supernatant were added to ELISA plates pre‐coated with a PGE2‐specific antibody and incubated with enzyme conjugate reagents. After a series of washing steps to remove unbound components, the substrate solution was added, and the reaction was allowed to develop at room temperature in the dark. The reaction was terminated by the addition of the stop solution, and absorbance was measured at 450 nm using a BioTek microplate reader. The assay was carried out in triplicate. The percentage of inhibition was relative to the control (Equation 1), and IC50 values were calculated from dose‐response curves using GraphPad Prism version 7. Antimicrobial Assay Antimicrobial activity of the essential oils was evaluated using the broth microdilution method [15]. Microorganisms were obtained from ATCC, Manassas, USA, including two Gram‐positive bacteria Bacillus cereus ATCC 14579 and Staphylococcus aureus ATCC 6538; two Gram‐negative bacteria Escherichia coli ATCC 8739 and Pseudomonas aeruginosa ATCC 10145; and the yeast Candida albicans ATCC 14053. All antimicrobial assays were carried out using Mueller‐Hinton Broth (MHB) supplemented with 0.5% (v/v) Tween 80 to enhance oil dispersion. Serial twofold dilutions of the essential oils were prepared in 96‐well microplates to obtain final concentrations ranging from 256 to 2048 µg/mL. Each well was loaded with 10 µL of the diluted essential oil and 10 µL of MHB, followed by the addition of 10 µL of microbial suspension (1 × 106 CFU/mL), yielding a final inoculum density of 1 × 104 CFU/mL. All experiments were conducted in triplicate. The microplates were incubated at 37°C for 24 h. Microbial growth was assessed visually by observing turbidity in the wells. Ampicillin (0.25‐16 µg/mL), tetracycline (0.5‐8 µg/mL), and nystatin (0.5‐32 µg/mL) were employed as the positive controls for the Gram‐positive bacteria, Gram‐negative bacteria, and yeast, respectively. The minimum inhibitory concentration (MIC) was defined as the lowest concentration of the test sample that completely prevented visible microbial growth. Statistical Analysis Experimental data were processed using Origin 2025 and reported as mean ± SD. Differences among groups were assessed by one‐way ANOVA, followed by Tukey's multiple comparison test, and values of p < 0.05 were regarded as statistically significant. Computational Procedure ADME Properties and Physicochemical Parameters Following the identification of the major compounds, the SMILES series was used to simulate ADME and Lipinski's rule of five for these identified compounds. The SwissADME website (https://www.swissadme.ch/) was used to assess these properties. Toxicity Risk Prediction The Protox II website (http://tox.charite.de/protox_II) was further used to predict compounds' toxicity. The toxicity chemical class prediction is segmented into the following categories: Class 1 = extremely lethal (LD50 ≤ 5); class 2 = fatal (5< LD50 ≤ 50); class 3 = toxic (50< LD50 ≤ 300); class 4 = harmful (300< LD50 ≤ 2000); class 5 = possibly hazardous (2000< LD50 ≤ 5000); and class 6 = nontoxic (LD50> 5000) [17]. Molecular Docking The target proteins and the prospective ligands were developed for accurate computational calculations. The ligand preparation was done using the LigPrep tool interfaced with the Schrödinger suite's Maestro module. The optimal potential liquid simulations (OPLS4) force field was used to create and minimize the 3D structures of ligand and all the reference compounds (oxypurinol, ibuprofen, and meclofenamate) that included all potential tautomers and ionization states at pH 7.0 ± 2.0. The protein preparations were made using Schrödinger's multi‐step Protein Preparation Wizard, PrepWizard. Xanthine oxidase (XO), cyclooxygenase (COX‐1 and ‐2), and 5‐lipoxygenase (5‐LOX) high‐resolution protein crystal structures at 2 Å resolution were first obtained from the RCSB Protein Data Bank (PDB ID: 3NVY, 6Y3C, 1PXX, and 6N2W, respectively). After adding hydrogen atoms to the heavy atoms and assigning charges and bond orders, all water molecules and heteroatoms were eliminated. The final structure of the ligand and proteins was optimized, and their energy was minimized using the OPLS4 force field. The binding pocket was represented by a grid that was created. The discovered compounds and reference standards were docked into the active site of the crystal structures using the Schrödinger Suite's Glide XP (enhanced precision) module [18]. The molecule's best‐scoring docked position, the bound ligand's conformation, and the RMSD were computed and visualized using Schrödinger Suite's Maestro module and Discovery Studio Visualizer Client (Windows 64‐bit). Results and Discussion Chemical Analysis Hydro‐distillation of the fresh stem bark afforded a yellowish essential oil, yielding 0.28% (w/w). From GC‐MS analysis, a total of 67 compounds were identified, which reached 99.56% (Table 1 and Figure S1). The obtained oil was characterized by the presence of oxygenated sesquiterpenes (62.41%), sesquiterpene hydrocarbons (17.98%), and non‐terpenic compounds (16.79%). The remaining class was oxygenated monoterpenes (2.37%). The predominant compounds found in this sample included (Z)‐Dihydro‐apofarnesol (13.84%), ishwarane (8.96%), spathulenol (7.87%), palmitic acid (7.58%), and (E)‐dihydro‐apofarnesol (6.71%). In addition, several other compounds were present at concentrations exceeding 1.00%, for example, α‐bisabolol (4.09%), selin‐11‐en‐4‐α‐ol (2.88%), junicedranol (2.86%), and humulene epoxide II (2.20%). TABLE 1Chemical compositions (%) in B. papyrifera essential oils.RTCompoundsRIE RIL Stem barkLeavesClass3.331‐Methyl‐1,3‐cyclohexadiene7787710.20 ± 0.0006NT3.383‐Methyl‐2‐butenal7807780.37 ± 0.0011NT4.89(2E)‐Hexenal8478460.28 ± 0.00030.67 ± 0.0021NT4.98(3Z)‐Hexenol8518500.33 ± 0.00042.44 ± 0.0076NT5.22(2Z)‐Hexenol8628590.34 ± 0.0004NT5.27 n‐Hexanol8648630.80 ± 0.0010 16.64 ± 0.0519 NT8.05Benzaldehyde9589520.38 ± 0.0005NT8.906‐Methyl‐5‐hepten‐2‐one9849810.87 ± 0.0011NT12.47 cis‐Linalool oxide (furanoid)107310670.72 ± 0.0009OM13.14 trans‐Linalool oxide (furanoid)108910840.74 ± 0.0009OM22.53 n‐Tridecane130013002.07 ± 0.00262.81 ± 0.0088NT24.22 δ‐Elemene133913350.30 ± 0.00040.31 ± 0.0010SH25.52Cyclosativene137013690.28 ± 0.0003SH25.72 α‐Ylangene137413730.30 ± 0.0004SH26.58 β‐Elemene139413890.92 ± 0.00111.38 ± 0.0043SH28.07(E)‐α‐Ionone143014280.31 ± 0.0004OM28.19 β‐Copaene143314300.44 ± 0.0005SH29.05 α‐Humulene145414520.87 ± 0.00110.78 ± 0.0024SH29.20(E)‐β‐Farnesene145814540.28 ± 0.0003SH29.56Ishwarane14661465 8.96 ± 0.0111 7.33 ± 0.0229 SH30.03 trans‐Cadina‐1(6),4‐diene147814750.74 ± 0.0023SH30.11 γ‐Muurolene148014780.49 ± 0.00060.36 ± 0.0011SH30.25Germacrene D148314800.18 ± 0.0002SH30.44(E)‐β‐Ionone148814870.60 ± 0.00070.84 ± 0.0026OM30.59 β‐Selinene149114890.99 ± 0.00121.39 ± 0.0043SH30.95Bicyclogermacrene150015000.21 ± 0.0003SH31.07 α‐Muurolene150315000.97 ± 0.00120.44 ± 0.0014SH31.40Germacrene A151115080.26 ± 0.0003SH31.53 δ‐Amorphene151515110.51 ± 0.00060.29 ± 0.0009SH31.63 γ‐Cadinene151715130.73 ± 0.00090.76 ± 0.0024SH31.76Myristicin152115170.05 ± 0.0001NT31.98 δ‐Cadinene152615220.81 ± 0.00100.76 ± 0.0024SH32.28(E)‐γ‐Bisabolene153415290.48 ± 0.00060.56 ± 0.0018SH33.19(E)‐Veltonal155715552.15 ± 0.00271.52 ± 0.0048OS33.54(E)‐Nerolidol156615610.89 ± 0.0011OS33.74(Z)‐Dihydro‐apofarnesol15711571 13.84 ± 0.0171 6.41 ± 0.0200 OS33.90Euasarone157515720.16 ± 0.0002OS34.16Spathulenol15821577 7.87 ± 0.0097 34.78 ± 0.1085 OS34.24Hexyl benzoate158415790.58 ± 0.0007NT34.39Caryophyllene oxide158815821.84 ± 0.00233.86 ± 0.0120OS34.59(E)‐Dihydro‐apofarnesol15931590 6.71 ± 0.0083 OS34.79Salvial‐4(14)‐en‐1‐one159815950.81 ± 0.00100.68 ± 0.0021OS34.96Guaiol160216000.56 ± 0.0007OS35.03Ledol160416021.06 ± 0.00131.09 ± 0.0034OS35.32Humulene epoxide II161216082.20 ± 0.00271.23 ± 0.0038OS35.39Tetradecanal161416111.35 ± 0.00170.40 ± 0.0013NT35.88Humulane‐1,6‐dien‐3‐ol162316190.62 ± 0.00080.37 ± 0.0012OS35.88 trans‐Isolongifolanone162716250.83 ± 0.00100.29 ± 0.0009OS36.011‐epi‐Cubenol163116270.66 ± 0.00080.29 ± 0.0009OS36.10Isospathulenol163316310.96 ± 0.00122.58 ± 0.0081OS36.26 cis‐Cadin‐4‐en‐7‐ol163716350.58 ± 0.00070.41 ± 0.0013OS36.56 α‐Muurolol164516440.70 ± 0.00091.23 ± 0.0038OS36.76Cubenol165116450.58 ± 0.00071.00 ± 0.0031OS37.07Selin‐11‐en‐4‐α‐ol165916582.88 ± 0.00362.11 ± 0.0066OS37.21Allohimachalol166316610.62 ± 0.00080.95 ± 0.0030OS37.83Khusilol167916751.68 ± 0.00210.93 ± 0.0029OS37.95Mustakone168216801.03 ± 0.00130.41 ± 0.0013OS38.09 epi‐α‐Bisabolol168616830.81 ± 0.0010OS38.28 α‐Bisabolol169116854.09 ± 0.0051OS38.49Junicedranol169716922.86 ± 0.0035OS38.74Heptadecane170117001.37 ± 0.0017NT38.74Juniper camphor170417001.37 ± 0.0017OS38.83Mayurone170717030.35 ± 0.0004OS39.2214‐Hydroxy‐α‐humulene171717131.21 ± 0.0015OS40.30(2E,6E)‐Farnesol174817420.36 ± 0.0004OS41.11 β‐Costol177117651.29 ± 0.0016OS41.32 n‐Pentadecanol177717730.40 ± 0.0005NT43.75Hexahydrofarnesyl acetone184718450.84 ± 0.0010OS46.46Methyl palmitate192919210.39 ± 0.0005NT47.72Palmitic acid19681959 7.58 ± 0.0094 NTTotal99.56 ± 0.116899.64 ± 0.3137Oxygenated monoterpenes (OM)2.37 ± 0.00291.93 ± 0.0060Sesquiterpene hydrocarbons (SH)17.98 ± 0.022115.10 ± 0.0472Oxygenated sesquiterpenes (OS)62.41 ± 0.077259.05 ± 0.1843Non‐terpenic compounds (NT)16.79 ± 0.020923.53 ± 0.0734RT: Retention time; RIE: Experimental retention indices; RIL: Literature retention indices. bold: major compound (≥ 5%). Chemical compositions (%) in B. papyrifera essential oils. RT: Retention time; RIE: Experimental retention indices; RIL: Literature retention indices. bold: major compound (≥ 5%). The essential oil (0.29%, w/w) obtained from the leaves also appeared with a yellowish color. As shown in Table 1 and Figure S2, 38 compounds were identified, which accounted for 99.64%. Oxygenated sesquiterpenes (59.05%) were still the most abundant class, followed by non‐terpenic compounds (23.53%) and sesquiterpene hydrocarbons (15.10%), while the content of oxygenated monoterpenes was 1.93%. By this finding, the stem bark oil is rich in terpenes, but has less amount of non‐terpenic compounds, compared to the leaf oil. The major compounds recorded in the leaf oil consisted of spathulenol (34.78%), n‐hexanol (16.64%), ishwarane (7.33%), (Z)‐dihydro‐apofarnesol (6.41%). Moreover, several other compounds were detected at levels higher than 1.00%, for example, caryophyllene oxide (3.86%), n‐tridecane (2.81%), and (3Z)‐hexenol (2.44%). A drastic variation in chemical compositions was observed between the two samples. (E)‐Dihydro‐apofarnesol and palmitic acid were only found in the stem bark oil. n‐Hexanol predominated in the leaf oil, but was less important in the stem bark oil. Spathulenol was found at a much higher level in the leaves than in the stems. Cytotoxic Activity The two oil samples have been subjected to cytotoxic evaluation against the growth of two cancer cell lines MCF‐7 and HepG2. At the highest tested concentration of 100 µg/mL, the stem bark oil exhibited 70.2%–75.1% inhibition, compared to that of the leaf oil (76.2%–82.4%) (Figure 1). When the concentration was reduced, the observed inhibition decreased. At the intermediate doses of 20 and 4 µg/mL, B. papyrifera essential oils were responsible for 20.3%–55.8% inhibition. At the lowest tested concentration of 0.8 µg/mL, the inhibitory proportions were less than 7.1%. Cytotoxicity of B. papyrifera essential oils. Mean ± SD, n value = 3, p < 0.05 v.s. the non‐treated group. The obtained IC50 values align with the inhibitory rates. For Table 2, the stem bark oil exerted IC50 values of 48.7 ± 2.40 and 56.3 ± 2.70 µg/mL against MCF‐7 and HepG2, respectively. In the meantime, the leaf oil showed better with the corresponding IC50 values of 33.2 ± 1.90 and 41.0 ± 2.20 µg/mL. Compared to the standard ellipticine (IC50 = 2.22‐2.32 µg/mL), B. papyrifera essential oils exhibited moderate cytotoxicity. TABLE 2The IC50 values (µg/mL) of B. papyrifera essential oils in the biological activities.SamplesCytotoxicityDPPH radical scavengingAnti‐inflammatory activityNO inhibitionPGE2 inhibitionMCF‐7HepG2Stem bark48.7 ± 2.4056.3 ± 2.7047.83 ± 2.5137.21 ± 1.8088.70 ± 2.23Leaves33.2 ± 1.9041.0 ± 2.2033.15 ± 2.3424.15 ± 1.3552.30 ± 2.47Ellipticine2.32 ± 0.022.22 ± 0.01Ascorbic acid13.64 ± 0.02L‐NMMA11.07 ± 0.77NO: Nitric oxide; PGE2: Prostaglandin E2; L‐NMMA: NG‐Monomethyl‐L‐arginine acetate The IC50 values (µg/mL) of B. papyrifera essential oils in the biological activities. NO: Nitric oxide; PGE2: Prostaglandin E2; L‐NMMA: NG‐Monomethyl‐L‐arginine acetate This is the first time we report the cytotoxicity of Broussonetia essential oils. B. papyrifera is also appropriate for anticancer treatment since its extract and isolates exhibited potential results. By the MTT assay, the MeOH leaf extract yielded IC50 values of 87.5 µg/mL for MCF‐7 and 106.2 µg/mL for HeLa cells [19]. The MeOH bark extract showed stronger cytotoxic activity against the HeLa cell line, with IC50 values of 75.3 and 88.3 µg/mL in the trypan blue and MTT assays, respectively [19]. Following the recent report, a new flavonoid, namely broussopapyrin A, exhibited better cytotoxicity against breast cancer cell lines MCF‐7 and MDA‐MB‐231 than the standard 5‐FU, together with 2‐2.5‐fold greater safety at effective concentrations relative to doxorubicin [20]. Antioxidative Activity The antioxidative potential of B. papyrifera oil samples was evaluated using the free 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) radical scavenging assay. At the highest tested concentration of 250 µg/mL, the essential oils from B. papyrifera stem bark and leaves caused 83.94% and 88.29% inhibition, respectively (Figure 2). At 100 µg/mL, the inhibitory rates ranged from 67.65% to 75.1%. In comparison, these inhibitory values were found to be 55.11%–60.13% at 50 µg/mL. The inhibitory percentages were 17.29%–44.99% at lower doses of 10‐25 µg/mL, and only 9.46%–13.11% at the lowest concentration of 5 µg/mL. DPPH radical scavenging of B. papyrifera essential oils. Mean ± SD, n value = 3, p < 0.05 v.s. the non‐treated group. As a result, the leaf oil was associated with an IC50 value of 33.15 ± 2.34 µg/mL, which was better than that of the stem bark oil (IC50 = 47.83 ± 2.51 µg/mL). In comparison with the standard ascorbic acid (IC50 = 13.64 ± 0.02 µg/mL), B. papyrifera oil collected from Vietnam showed strong DPPH radical scavenging activity. Sun et al. (2012) also suggested that the antioxidant effects of B. papyrifera extracts may relate to the presence of phenolic compounds, in which the polar extracts of its fruits were able to quench DPPH radicals, chelate to the metal Fe2+ ion, and exhibit reducing power [6]. Besides cytotoxicity, broussopapyrin A enables scavenging DPPH (SC50 = 22.33 µM) and ABTS (SC50 = 15.15 µM) radicals, which were remarkably better than the standard butylated hydroxytoluene (DPPH SC50 = 139.41 µM, and ABTS SC50 = 92.15 µM) [19]. The results of this study further confirm the important role of B. papyrifera constituents in antioxidant activity. Anti‐Inflammatory Activity B. papyrifera essential oils have been further subjected to evaluate anti‐inflammatory activities against NO and PGE2 production in LPS‐stimulated RAW 264.7 cells. At the tested concentrations of 4‐256 µg/mL, the essential oils have no toxicity on the cells, with viability exceeding 80% (Figure 3). At 256 µg/mL, the stem bark and leaf oils possessed 87.4% and 91.4% inhibition, respectively. The inhibitory values fluctuated from 63.4% to 72.7% at 64 µg/mL, and from 30.2% to 40% at 16 µg/mL. At the lowest concentration of 4 µg/mL, the inhibitory percentages were found to be less than 15% (Figure 3). By means of this, the essential oils from B. papyrifera stem bark and leaves exerted IC50 values of 37.21 ± 1.80 and 24.15 ± 1.35 µg/mL, respectively. Compared to the standard L‐NMMA (IC50 11.07 ± 0.77 µg/mL), B. papyrifera essential oils showed strong NO inhibitory activity. Anti‐inflammatory activity of B. papyrifera essential oils. Mean ± SD, n value = 3, p < 0.05 v.s. the non‐treated group. Considering the second assay, the stem bark and leaf oils caused the corresponding 79.6% and 83.5% inhibition at the highest tested concentration of 256 µg/mL (Figure 3). Lower concentrations led to decreased inhibition. At the intermediate concentrations of 16–64 µg/mL, the inhibitory proportion ranged from 22.3% to 63.2%. At the lowest dose of 4 µg/mL, the percentages were less than 13%. As a consequence, IC50 values of 88.70 ± 2.23 and 52.30 ± 2.47 µg/mL were assigned to the stem bark and leaf oils, respectively. The beneficial effects of B. papyrifera wood in anti‐inflammatory treatments may be due to the suppression of cytokines IL‐1 and TNF‐α from its phenolic compounds [21]. Both B. papyrifera root bark extract and its isolated compound, kazinol J, were reported to exhibit anti‐inflammatory effects on adipose tissue and improve insulin sensitivity, potentially via the activation of the AMPK signaling pathway [22]. The current study first reports the anti‐inflammatory activities of Broussonetia essential oils, reinforcing the role of B. papyrifera crude extracts, essential oils, and isolates in the treatment of inflammatory conditions. Antimicrobial Activity In the final assay, B. papyrifera aerial part essential oils collected from Vietnam were evaluated for their antimicrobial activity. As shown in Table 3, the stem bark oil exhibited inhibitory activity against the Gram‐positive bacteria B. cereus and S. aureus, with MIC values of 512 and 256 µg/mL, respectively. These values were higher than those observed for the leaf oil (MICs of 256 and 128 µg/mL, respectively) and markedly higher than that of the reference antibiotic ampicillin (MIC = 8 µg/mL). TABLE 3MIC values (µg/mL) in antimicrobial assay of B. papyrifera essential oils.Microbial strainsStem barkLeavesAmpicillinTetracyclineNystatinGram‐positive bacteria Bacillus cereus 5122568 Staphylococcus aureus 2561288Gram‐negative bacteria Escherichia coli 10245124 Pseudomonas aeruginosa 102410244Yeast Candida albicans 5122568 MIC values (µg/mL) in antimicrobial assay of B. papyrifera essential oils. Two samples exhibited weak activity against the Gram‐negative bacteria E. coli and P. aeruginosa, with MIC values ranging from 512 to 1024 µg/mL. Meanwhile, the essential oils from B. papyrifera stem bark and leaves exhibited moderate activity against the yeast C. albicans with MIC values of 512 and 256 µg/mL, respectively. It was noted that the leaf oil is always better than the stem bark oil in all biological assays. This may be due to the major compounds, like n‐hexanol and spathulenol. The current results are in agreement with previous records. B. papyrifera seed oil, containing a high content of aliphatic compounds, exhibited antimicrobial effects on B. cereus, S. aureus, Enterobacter aerogenes, and Proteus vulgaris with MIC values of 0.125%–0.5% [7]. In another report, 5,7,3',4'‐tetrahydroxy‐3‐methoxy‐8,5'‐diprenylflavone, isolated from B. papyrifera aerial parts, showed more antibacterial activity against Actinomyces naeslundii and Porphyromonas gingivalis (MIC = 1.95 µg/mL) than the standard triclosan at 0.12‐250 µg/mL [23]. In Silico Approach As we know, oxidative stress and inflammation are closely interconnected pathological processes that play critical roles in the initiation and progression of various immune‐related disorders [24]. To further rationalize antioxidant and anti‐inflammatory activities, an integrated in silico approach has been employed, combining ADME‐physicochemical profiling, toxicity prediction, and molecular docking analysis of B. papyrifera essential oils’ major constituents n‐hexanol (1), ishwarane (2), (E)‐dihydro‐apo‐farnnesol (3), (Z)‐dihydro‐apo‐farnnesol (4), palmitic acid (5), and spathulenol (6). As shown in Tables 4 and 5, all the studied compounds exhibited acceptable physicochemical characteristics and favorable drug‐likeness profiles. Their molecular weights were below 500 g/mol, with moderate lipophilicity and low topological polar surface areas, supporting good membrane permeability. Except for compound 5, which showed poor solubility, most compounds were predicted to be soluble or moderately soluble. Strikingly, compounds 3‐4 and 6 exhibited high gastrointestinal absorption and blood‐brain barrier permeability, while none were predicted to be P‐glycoprotein substrates, suggesting favorable oral bioavailability. TABLE 4Physicochemical properties of compounds 1‐6.NoMW (g/mol)NHBAsNHBDs Consensus (LogPo/w) Rule of Five TPSA (A°2) NRBsWater solubility class 1 102.17111.69020.234Soluble 2 204.35004.5210.000Moderately soluble 3 224.38114.47020.238Moderately soluble 4 210.36113.94020.237Moderately soluble 5 256.42215.20137.3014Poorly soluble 6 220.35103.30020.231Soluble Physicochemical properties of compounds 1‐6. Consensus (LogPo/w) Rule of Five TPSA (A°2) TABLE 5The predicted ADME profile of compounds 1‐6.NoHIABBBPgpCYP1A2CYP2C19CYP2C9CYP2D6CYP3A4log Kppermeantsubstrateinhibitorinhibitorinhibitorinhibitorinhibitor(cm/s) 1 HighYesNoNoNoNoNoNo−5.48 2 LowYesNoYesYesYesNoNo−3.78 3 HighYesNoYesNoYesNoNo−3.57 4 HighYesNoNoNoYesNoNo−4.38 5 HighYesNoYesNoYesNoNo−2.77 6 HighYesNoNoYesNoNoNo−5.44 The predicted ADME profile of compounds 1‐6. The toxicity prediction results (Table 6) indicated that all compounds 1‐6 belong to toxicity classes 4‐6, corresponding to harmful to non‐toxic categories, with relatively high LD50 values. None of the ligands exhibited predicted hepatotoxicity, nephrotoxicity, cardiotoxicity, or carcinogenicity. Only spathulenol (6) showed a moderate probability of respiratory toxicity, while all other toxicity endpoints were expected to be inactive, confirming a general low toxicological risk. TABLE 6Toxicity profile of compounds 1‐6.NoToxicity class (LD50)Average similarityPrediction accuracyHepatotoxicityNephrotoxicityRespiratory toxicityCardio‐toxicityCarcino‐toxicity 1 4 (710 mg/kg)100%100%InactiveInactiveInactiveInactiveInactive(p = 0.90)(p = 0.67)(p = 0.93)(p = 1.0)(p = 0.5) 2 6 (15380 mg/kg)73.33%69.26%InactiveInactiveInactiveInactiveInactive(p = 0.82)(p = 0.92)(p = 0.57)(p = 0.79)(p = 0.64) 3 6 (5600 mg/kg)87.37%70.97%InactiveInactiveInactiveInactiveInactive(p = 0.84)(p = 0.73)(p = 0.89)(p = 0.85)(p = 0.65) 4 5 (5000 mg/kg)80.25%70.97%InactiveInactiveInactiveInactiveInactive(p = 0.77)(p = 0.73)(p = 0.82)(p = 0.77)(p = 0.77) 5 4 (900 mg/kg)100%100%InactiveInactiveInactiveInactiveInactive(p = 0.52)(p = 0.53)(p = 0.85)(p = 0.99)(p = 0.63) 6 5 (3900 mg/kg)81.7470.97InactiveInactiveActiveInactiveInactive(p = 0.86)(p = 0.90)(p = 0.69)(p = 0.85)(p = 0.61) Toxicity profile of compounds 1‐6. Molecular docking simulations against key inflammation‐ and oxidative stress‐related enzymes, including COX‐1 (ID: 6Y3C), COX‐2 (ID: 1PXX), 5‐LOX (ID: 6N2W), and XO (ID: 3NVY), revealed stable binding conformations of all ligands 1‐6 within the catalytic pockets (Figures 4, 5, 6, 7). As we know, COX‐1 and COX‐2 are key regulators of prostaglandin biosynthesis in inflammatory responses, 5‐LOX is critically involved in leukotriene‐mediated inflammation, while XO is a major enzymatic source of reactive oxygen species, thereby mechanistically linking inflammation with oxidative stress [25, 26, 27, 28, 29]. The 2D and 3D images of compounds 1‐6 in the active sites of COX‐1 (ID: 6Y3C). The 2D and 3D images of compounds 1‐6 in the active sites of COX‐2 (ID: 1PXX). The 2D and 3D images of compounds 1‐6 in the active sites of 5‐LOX (ID: 6N2W). The 2D and 3D images of compounds 1‐6 in the active sites of XO (ID: 3NVY). The calculated binding energies (Table S1) ranged from −4.3 to −8.0 kcal/mol, indicating moderate to strong binding affinities. Among the tested compounds, compound 3 exhibited the strongest interactions, with binding energies of −8.0 kcal/mol for COX‐2, −7.4 kcal/mol for COX‐1, −7.1 kcal/mol for 5‐LOX, and −7.2 kcal/mol for XO. These values were comparable to, or even stronger than, those of the reference drugs ibuprofen (−7.4 and −7.0 kcal/mol for COX‐2 and COX‐1, respectively), meclofenamate (−7.0 kcal/mol for 5‐LOX), and oxypurinol (−6.2 kcal/mol for XO) (Figures S3–S5 and Table S1). Spathulenol (6) also displayed remarkable binding affinities, particularly toward COX‐2 and XO, with binding energies of −7.5 kcal/mol for both targets, closely matching the standard inhibitors. The docking poses indicated that these compounds have been mainly stabilized by hydrophobic interactions (π‐alkyl and π‐σ) together with hydrogen bonds involving key catalytic residues such as Ser530, Tyr385, Trp387 (COX enzymes), Arg438, and Lys441 (5‐LOX), and Glu1065 and Lys792 (XO), which are essential for enzymatic activity. Study Limitations Several limitations of the present study should be acknowledged. First, antioxidant activity was assessed using a single assay (DPPH radical scavenging); as different antioxidant mechanisms (e.g., ferric‐ or copper‐reducing power) can yield complementary information, future work incorporating additional methods such as FRAP or CUPRAC is warranted to more comprehensively characterize the redox activity of these essential oils. Second, cytotoxicity was evaluated only against the MCF‐7 and HepG2 cancer cell lines, without a parallel assay on a non‐cancerous/normal cell line; consequently, a selectivity index could not be calculated, and the observed activity should be interpreted as general cytotoxic potential rather than confirmed anticancer selectivity. Third, chemical quantification was semi‐quantitative, based on GC‐MS TIC peak‐area normalization without GC‐FID or authentic standards. These limitations will be addressed in follow‐up studies. Conclusion The essential oils obtained from the stem bark and leaves of B. papyrifera collected in Vietnam were comprehensively analyzed and biologically evaluated using an integrated experimental and computational approach. Chemical profiles between the two oils are characterized by the presence of terpenes and fatty acids, with oxygenated sesquiterpenes being the predominant constituents in both samples. Some compounds, for example, spathulenol, (Z)‐ and (E)‐dihydro‐apofarnesol, ishwarane, n‐hexanol, and palmitic acid, were identified as major compounds, which likely contributed to the multiple biological activities. Both essential oils exhibited moderate cytotoxic effects against MCF‐7 and HepG2 cancer cell lines, together with pronounced DPPH radical scavenging activity. Furthermore, significant anti‐inflammatory effects were observed through the NO and PGE2 inhibitions, particularly for the leaf oil, which consistently exhibited superior activity for all biological assays. In addition, the essential oils displayed moderate antimicrobial activity, with greater efficacy against the Gram‐positive bacteria and the yeast C. albicans than the Gram‐negative strains. The in silico studies further supported the experimental findings. ADME and toxicity predictions suggested favorable drug‐likeness, acceptable pharmacokinetic profiles, and low toxicological risks for the main compounds. Molecular docking studies revealed stable binding interactions of these compounds with the key enzymatic proteins COX‐1, COX‐2, 5‐LOX, and XO. Among them, (E)‐dihydro‐apofarnesol and spathulenol showed the strongest binding affinities, comparable to or exceeding those of standards, indicating their mechanistic roles in modulating inflammatory and oxidative pathways. Further investigations focusing on in vivo assays and molecular mechanism elucidation are warranted to fully explore their therapeutic potential. Author Contribution Phan Hong Minh, Ty Viet Pham and Shaza W. Shantier: formal analysis; Nguyen Thi Kim Thanh: resources, Nguyen Thi Huong, Nguyen Thi Thoa and Le The Hoai: validation; Tran Quang Hai, Huynh Thi Ngoc Ni and Vo Thi Dung: data curation; Ninh The Son: supervision, conceptualization, writing‐review and editing. Conflicts of Interest The authors declared no conflict of interest. Use of Generative AI During the preparation of this manuscript, the authors used ChatGPT for language editing. The graphical abstract was prepared by the authors using ChemDraw and PowerPoint and constitutes original artwork that accurately reflects the study's objectives, methodology, and key findings. No external, copyrighted, or AI‐generated illustrations were incorporated. All content was reviewed and edited by the authors, who take full responsibility for the accuracy and integrity of the manuscript. Supporting information Supporting File 1: cbdv71730‐sup‐0001‐SuppMat.docx. Acknowledgments The authors declare that no individuals, institutions, or organizations other than those already listed as coauthors contributed to this work in a manner requiring acknowledgement. Data Availability Statement The data that supports the findings of this study are available in the Supporting Information of this article References Associated Data Supplementary Materials Supporting File 1: cbdv71730‐sup‐0001‐SuppMat.docx. Data Availability Statement The data that supports the findings of this study are available in the Supporting Information of this article